BDBM62116 MLS000712760::N-[11-[3-(4-methyl-1-piperazinyl)-1-oxopropyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]-2-propylpentanamide;hydrochloride::N-[11-[3-(4-methylpiperazin-1-yl)propanoyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]-2-propyl-pentanamide;hydrochloride::N-[11-[3-(4-methylpiperazin-1-yl)propanoyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]-2-propylpentanamide;hydrochloride::N-[11-[3-(4-methylpiperazino)propanoyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]-2-propyl-valeramide;hydrochloride::SMR000282527::cid_16192866

SMILES O=C(c1cnc2c(c1)OCCN2c1ccn2c(=O)n(Cc3cccnc3)nc2c1)N1CCCCC1

InChI Key InChIKey=QKVCVVOYWQFGNS-UHFFFAOYSA-N

Data  1 IC50  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 62116   

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 62116BDBM62116(US12577217, Example 1-32)
Affinity DataIC50: 10nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/27/2026
Entry Details
US Patent